nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—HDAC2—chronic obstructive pulmonary disease	0.345	0.828	CbGaD
Valproic Acid—HDAC2—Aminophylline—chronic obstructive pulmonary disease	0.157	0.411	CbGbCtD
Valproic Acid—CYP1A2—chronic obstructive pulmonary disease	0.0715	0.172	CbGaD
Valproic Acid—SLC22A5—Tiotropium—chronic obstructive pulmonary disease	0.0306	0.0802	CbGbCtD
Valproic Acid—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.0261	0.0685	CbGbCtD
Valproic Acid—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.0261	0.0685	CbGbCtD
Valproic Acid—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.0198	0.0519	CbGbCtD
Valproic Acid—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.0169	0.0443	CbGbCtD
Valproic Acid—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0116	0.0304	CbGbCtD
Valproic Acid—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0108	0.0283	CbGbCtD
Valproic Acid—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0108	0.0283	CbGbCtD
Valproic Acid—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.00977	0.0256	CbGbCtD
Valproic Acid—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.00899	0.0235	CbGbCtD
Valproic Acid—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.00899	0.0235	CbGbCtD
Valproic Acid—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.00848	0.0222	CbGbCtD
Valproic Acid—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0069	0.0181	CbGbCtD
Valproic Acid—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.00681	0.0178	CbGbCtD
Valproic Acid—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00466	0.0122	CbGbCtD
Valproic Acid—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.00454	0.0119	CbGbCtD
Valproic Acid—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00444	0.0116	CbGbCtD
Valproic Acid—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00396	0.0104	CbGbCtD
Valproic Acid—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00232	0.00609	CbGbCtD
Valproic Acid—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00219	0.00575	CbGbCtD
Valproic Acid—OGDH—respiratory system—chronic obstructive pulmonary disease	0.00158	0.0637	CbGeAlD
Valproic Acid—HDAC9—respiratory system—chronic obstructive pulmonary disease	0.00139	0.0562	CbGeAlD
Valproic Acid—OGDH—connective tissue—chronic obstructive pulmonary disease	0.00139	0.0561	CbGeAlD
Valproic Acid—OGDH—bronchus—chronic obstructive pulmonary disease	0.0013	0.0525	CbGeAlD
Valproic Acid—UGT1A4—respiratory system—chronic obstructive pulmonary disease	0.00129	0.052	CbGeAlD
Valproic Acid—OGDH—trachea—chronic obstructive pulmonary disease	0.00117	0.0471	CbGeAlD
Valproic Acid—HDAC9—bronchus—chronic obstructive pulmonary disease	0.00114	0.0463	CbGeAlD
Valproic Acid—ACADSB—bronchus—chronic obstructive pulmonary disease	0.00103	0.0417	CbGeAlD
Valproic Acid—HDAC9—trachea—chronic obstructive pulmonary disease	0.00103	0.0415	CbGeAlD
Valproic Acid—ACADSB—trachea—chronic obstructive pulmonary disease	0.000926	0.0374	CbGeAlD
Valproic Acid—ALDH5A1—bronchus—chronic obstructive pulmonary disease	0.000908	0.0367	CbGeAlD
Valproic Acid—OGDH—lung—chronic obstructive pulmonary disease	0.000837	0.0338	CbGeAlD
Valproic Acid—CYP2C18—bronchus—chronic obstructive pulmonary disease	0.000775	0.0313	CbGeAlD
Valproic Acid—HDAC9—lung—chronic obstructive pulmonary disease	0.000738	0.0298	CbGeAlD
Valproic Acid—HDAC2—respiratory system—chronic obstructive pulmonary disease	0.000711	0.0287	CbGeAlD
Valproic Acid—ACADSB—lung—chronic obstructive pulmonary disease	0.000665	0.0269	CbGeAlD
Valproic Acid—HDAC2—connective tissue—chronic obstructive pulmonary disease	0.000626	0.0253	CbGeAlD
Valproic Acid—ALDH5A1—lung—chronic obstructive pulmonary disease	0.000586	0.0237	CbGeAlD
Valproic Acid—HDAC2—bronchus—chronic obstructive pulmonary disease	0.000585	0.0236	CbGeAlD
Valproic Acid—HDAC2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000572	0.0231	CbGeAlD
Valproic Acid—ABAT—lung—chronic obstructive pulmonary disease	0.000501	0.0203	CbGeAlD
Valproic Acid—HDAC2—lung—chronic obstructive pulmonary disease	0.000377	0.0153	CbGeAlD
Valproic Acid—SLC22A5—respiratory system—chronic obstructive pulmonary disease	0.000361	0.0146	CbGeAlD
Valproic Acid—SLC16A1—lung—chronic obstructive pulmonary disease	0.000335	0.0136	CbGeAlD
Valproic Acid—CYP2A6—lung—chronic obstructive pulmonary disease	0.00033	0.0134	CbGeAlD
Valproic Acid—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000327	0.0132	CbGeAlD
Valproic Acid—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.000315	0.0127	CbGeAlD
Valproic Acid—CYP2B6—respiratory system—chronic obstructive pulmonary disease	0.000313	0.0127	CbGeAlD
Valproic Acid—SLC22A5—bronchus—chronic obstructive pulmonary disease	0.000297	0.012	CbGeAlD
Valproic Acid—PTGS1—respiratory system—chronic obstructive pulmonary disease	0.000283	0.0115	CbGeAlD
Valproic Acid—SLC22A5—trachea—chronic obstructive pulmonary disease	0.000267	0.0108	CbGeAlD
Valproic Acid—CYP2B6—bronchus—chronic obstructive pulmonary disease	0.000258	0.0104	CbGeAlD
Valproic Acid—PTGS1—connective tissue—chronic obstructive pulmonary disease	0.000249	0.0101	CbGeAlD
Valproic Acid—PTGS1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000228	0.00922	CbGeAlD
Valproic Acid—PTGS1—trachea—chronic obstructive pulmonary disease	0.000209	0.00846	CbGeAlD
Valproic Acid—SLC22A5—lung—chronic obstructive pulmonary disease	0.000192	0.00775	CbGeAlD
Valproic Acid—CYP1A2—lung—chronic obstructive pulmonary disease	0.000174	0.00702	CbGeAlD
Valproic Acid—CYP3A5—lung—chronic obstructive pulmonary disease	0.000167	0.00677	CbGeAlD
Valproic Acid—CYP2B6—lung—chronic obstructive pulmonary disease	0.000166	0.00673	CbGeAlD
Valproic Acid—PTGS1—lung—chronic obstructive pulmonary disease	0.00015	0.00608	CbGeAlD
Valproic Acid—Myalgia—Salbutamol—chronic obstructive pulmonary disease	9.9e-05	0.000982	CcSEcCtD
Valproic Acid—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	9.9e-05	0.000982	CcSEcCtD
Valproic Acid—Urticaria—Tiotropium—chronic obstructive pulmonary disease	9.89e-05	0.000982	CcSEcCtD
Valproic Acid—Anxiety—Salbutamol—chronic obstructive pulmonary disease	9.86e-05	0.000979	CcSEcCtD
Valproic Acid—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	9.85e-05	0.000978	CcSEcCtD
Valproic Acid—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	9.85e-05	0.000978	CcSEcCtD
Valproic Acid—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	9.84e-05	0.000977	CcSEcCtD
Valproic Acid—Oedema—Montelukast—chronic obstructive pulmonary disease	9.84e-05	0.000977	CcSEcCtD
Valproic Acid—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	9.84e-05	0.000977	CcSEcCtD
Valproic Acid—Tachycardia—Formoterol—chronic obstructive pulmonary disease	9.81e-05	0.000973	CcSEcCtD
Valproic Acid—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	9.81e-05	0.000973	CcSEcCtD
Valproic Acid—Discomfort—Salbutamol—chronic obstructive pulmonary disease	9.78e-05	0.00097	CcSEcCtD
Valproic Acid—Infection—Montelukast—chronic obstructive pulmonary disease	9.78e-05	0.00097	CcSEcCtD
Valproic Acid—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	9.77e-05	0.000969	CcSEcCtD
Valproic Acid—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	9.76e-05	0.000969	CcSEcCtD
Valproic Acid—Skin disorder—Formoterol—chronic obstructive pulmonary disease	9.76e-05	0.000969	CcSEcCtD
Valproic Acid—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	9.73e-05	0.000965	CcSEcCtD
Valproic Acid—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	9.68e-05	0.000961	CcSEcCtD
Valproic Acid—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	9.67e-05	0.000959	CcSEcCtD
Valproic Acid—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	9.65e-05	0.000958	CcSEcCtD
Valproic Acid—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	9.64e-05	0.000956	CcSEcCtD
Valproic Acid—Skin disorder—Montelukast—chronic obstructive pulmonary disease	9.56e-05	0.000949	CcSEcCtD
Valproic Acid—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	9.52e-05	0.000945	CcSEcCtD
Valproic Acid—Oedema—Salbutamol—chronic obstructive pulmonary disease	9.49e-05	0.000942	CcSEcCtD
Valproic Acid—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	9.49e-05	0.000942	CcSEcCtD
Valproic Acid—Infection—Salbutamol—chronic obstructive pulmonary disease	9.43e-05	0.000935	CcSEcCtD
Valproic Acid—Hypotension—Arformoterol—chronic obstructive pulmonary disease	9.39e-05	0.000932	CcSEcCtD
Valproic Acid—Hypotension—Formoterol—chronic obstructive pulmonary disease	9.39e-05	0.000932	CcSEcCtD
Valproic Acid—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	9.38e-05	0.000931	CcSEcCtD
Valproic Acid—Pruritus—Aminophylline—chronic obstructive pulmonary disease	9.34e-05	0.000927	CcSEcCtD
Valproic Acid—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	9.32e-05	0.000925	CcSEcCtD
Valproic Acid—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	9.3e-05	0.000923	CcSEcCtD
Valproic Acid—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	9.26e-05	0.000919	CcSEcCtD
Valproic Acid—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	9.22e-05	0.000915	CcSEcCtD
Valproic Acid—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	9.17e-05	0.00091	CcSEcCtD
Valproic Acid—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	9.17e-05	0.00091	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	9.16e-05	0.000908	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	9.16e-05	0.000908	CcSEcCtD
Valproic Acid—Insomnia—Arformoterol—chronic obstructive pulmonary disease	9.09e-05	0.000902	CcSEcCtD
Valproic Acid—Insomnia—Formoterol—chronic obstructive pulmonary disease	9.09e-05	0.000902	CcSEcCtD
Valproic Acid—Anorexia—Salbutamol—chronic obstructive pulmonary disease	9.04e-05	0.000897	CcSEcCtD
Valproic Acid—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	9.03e-05	0.000896	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	8.97e-05	0.00089	CcSEcCtD
Valproic Acid—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	8.96e-05	0.000889	CcSEcCtD
Valproic Acid—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	8.96e-05	0.000889	CcSEcCtD
Valproic Acid—Somnolence—Formoterol—chronic obstructive pulmonary disease	8.93e-05	0.000886	CcSEcCtD
Valproic Acid—Somnolence—Arformoterol—chronic obstructive pulmonary disease	8.93e-05	0.000886	CcSEcCtD
Valproic Acid—Insomnia—Montelukast—chronic obstructive pulmonary disease	8.9e-05	0.000883	CcSEcCtD
Valproic Acid—Hypotension—Salbutamol—chronic obstructive pulmonary disease	8.87e-05	0.00088	CcSEcCtD
Valproic Acid—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	8.85e-05	0.000878	CcSEcCtD
Valproic Acid—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	8.85e-05	0.000878	CcSEcCtD
Valproic Acid—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	8.84e-05	0.000877	CcSEcCtD
Valproic Acid—Pruritus—Tiotropium—chronic obstructive pulmonary disease	8.81e-05	0.000874	CcSEcCtD
Valproic Acid—Injury—Prednisone—chronic obstructive pulmonary disease	8.75e-05	0.000869	CcSEcCtD
Valproic Acid—Somnolence—Montelukast—chronic obstructive pulmonary disease	8.75e-05	0.000868	CcSEcCtD
Valproic Acid—Dizziness—Aminophylline—chronic obstructive pulmonary disease	8.73e-05	0.000866	CcSEcCtD
Valproic Acid—Weight increased—Prednisolone—chronic obstructive pulmonary disease	8.71e-05	0.000864	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	8.68e-05	0.000861	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	8.68e-05	0.000861	CcSEcCtD
Valproic Acid—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	8.66e-05	0.00086	CcSEcCtD
Valproic Acid—Fatigue—Formoterol—chronic obstructive pulmonary disease	8.66e-05	0.00086	CcSEcCtD
Valproic Acid—Fatigue—Arformoterol—chronic obstructive pulmonary disease	8.66e-05	0.00086	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	8.64e-05	0.000858	CcSEcCtD
Valproic Acid—Pain—Formoterol—chronic obstructive pulmonary disease	8.59e-05	0.000853	CcSEcCtD
Valproic Acid—Constipation—Arformoterol—chronic obstructive pulmonary disease	8.59e-05	0.000853	CcSEcCtD
Valproic Acid—Pain—Arformoterol—chronic obstructive pulmonary disease	8.59e-05	0.000853	CcSEcCtD
Valproic Acid—Constipation—Formoterol—chronic obstructive pulmonary disease	8.59e-05	0.000853	CcSEcCtD
Valproic Acid—Insomnia—Salbutamol—chronic obstructive pulmonary disease	8.58e-05	0.000852	CcSEcCtD
Valproic Acid—Increased appetite—Prednisone—chronic obstructive pulmonary disease	8.56e-05	0.00085	CcSEcCtD
Valproic Acid—Amnesia—Prednisone—chronic obstructive pulmonary disease	8.56e-05	0.00085	CcSEcCtD
Valproic Acid—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	8.52e-05	0.000845	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	8.5e-05	0.000843	CcSEcCtD
Valproic Acid—Fatigue—Montelukast—chronic obstructive pulmonary disease	8.49e-05	0.000842	CcSEcCtD
Valproic Acid—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	8.46e-05	0.000839	CcSEcCtD
Valproic Acid—Somnolence—Salbutamol—chronic obstructive pulmonary disease	8.44e-05	0.000837	CcSEcCtD
Valproic Acid—Pain—Montelukast—chronic obstructive pulmonary disease	8.42e-05	0.000835	CcSEcCtD
Valproic Acid—Vomiting—Aminophylline—chronic obstructive pulmonary disease	8.39e-05	0.000833	CcSEcCtD
Valproic Acid—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	8.35e-05	0.000829	CcSEcCtD
Valproic Acid—Rash—Aminophylline—chronic obstructive pulmonary disease	8.32e-05	0.000826	CcSEcCtD
Valproic Acid—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	8.32e-05	0.000825	CcSEcCtD
Valproic Acid—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	8.29e-05	0.000823	CcSEcCtD
Valproic Acid—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	8.28e-05	0.000822	CcSEcCtD
Valproic Acid—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	8.28e-05	0.000822	CcSEcCtD
Valproic Acid—Headache—Aminophylline—chronic obstructive pulmonary disease	8.27e-05	0.000821	CcSEcCtD
Valproic Acid—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	8.25e-05	0.000818	CcSEcCtD
Valproic Acid—Dizziness—Tiotropium—chronic obstructive pulmonary disease	8.23e-05	0.000817	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	8.22e-05	0.000815	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	8.22e-05	0.000815	CcSEcCtD
Valproic Acid—Lethargy—Prednisone—chronic obstructive pulmonary disease	8.21e-05	0.000815	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	8.19e-05	0.000813	CcSEcCtD
Valproic Acid—Fatigue—Salbutamol—chronic obstructive pulmonary disease	8.18e-05	0.000812	CcSEcCtD
Valproic Acid—Pain—Salbutamol—chronic obstructive pulmonary disease	8.11e-05	0.000805	CcSEcCtD
Valproic Acid—Constipation—Salbutamol—chronic obstructive pulmonary disease	8.11e-05	0.000805	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	8.05e-05	0.000799	CcSEcCtD
Valproic Acid—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	8.05e-05	0.000798	CcSEcCtD
Valproic Acid—Urticaria—Formoterol—chronic obstructive pulmonary disease	7.98e-05	0.000792	CcSEcCtD
Valproic Acid—Urticaria—Arformoterol—chronic obstructive pulmonary disease	7.98e-05	0.000792	CcSEcCtD
Valproic Acid—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	7.94e-05	0.000788	CcSEcCtD
Valproic Acid—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	7.94e-05	0.000788	CcSEcCtD
Valproic Acid—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	7.94e-05	0.000788	CcSEcCtD
Valproic Acid—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	7.94e-05	0.000788	CcSEcCtD
Valproic Acid—Affect lability—Prednisone—chronic obstructive pulmonary disease	7.92e-05	0.000786	CcSEcCtD
Valproic Acid—Vomiting—Tiotropium—chronic obstructive pulmonary disease	7.92e-05	0.000786	CcSEcCtD
Valproic Acid—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	7.86e-05	0.00078	CcSEcCtD
Valproic Acid—Rash—Tiotropium—chronic obstructive pulmonary disease	7.85e-05	0.000779	CcSEcCtD
Valproic Acid—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	7.84e-05	0.000778	CcSEcCtD
Valproic Acid—Nausea—Aminophylline—chronic obstructive pulmonary disease	7.84e-05	0.000778	CcSEcCtD
Valproic Acid—Urticaria—Montelukast—chronic obstructive pulmonary disease	7.82e-05	0.000776	CcSEcCtD
Valproic Acid—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	7.82e-05	0.000776	CcSEcCtD
Valproic Acid—Headache—Tiotropium—chronic obstructive pulmonary disease	7.8e-05	0.000774	CcSEcCtD
Valproic Acid—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	7.8e-05	0.000774	CcSEcCtD
Valproic Acid—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	7.78e-05	0.000772	CcSEcCtD
Valproic Acid—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	7.78e-05	0.000772	CcSEcCtD
Valproic Acid—Face oedema—Prednisone—chronic obstructive pulmonary disease	7.77e-05	0.000771	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	7.76e-05	0.00077	CcSEcCtD
Valproic Acid—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	7.7e-05	0.000764	CcSEcCtD
Valproic Acid—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	7.66e-05	0.00076	CcSEcCtD
Valproic Acid—Mood swings—Prednisone—chronic obstructive pulmonary disease	7.62e-05	0.000756	CcSEcCtD
Valproic Acid—Urticaria—Salbutamol—chronic obstructive pulmonary disease	7.54e-05	0.000748	CcSEcCtD
Valproic Acid—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	7.5e-05	0.000744	CcSEcCtD
Valproic Acid—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	7.5e-05	0.000744	CcSEcCtD
Valproic Acid—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	7.4e-05	0.000735	CcSEcCtD
Valproic Acid—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	7.4e-05	0.000735	CcSEcCtD
Valproic Acid—Nausea—Tiotropium—chronic obstructive pulmonary disease	7.4e-05	0.000734	CcSEcCtD
Valproic Acid—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	7.38e-05	0.000732	CcSEcCtD
Valproic Acid—Dry skin—Prednisone—chronic obstructive pulmonary disease	7.37e-05	0.000732	CcSEcCtD
Valproic Acid—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	7.25e-05	0.00072	CcSEcCtD
Valproic Acid—Asthenia—Arformoterol—chronic obstructive pulmonary disease	7.21e-05	0.000715	CcSEcCtD
Valproic Acid—Asthenia—Formoterol—chronic obstructive pulmonary disease	7.21e-05	0.000715	CcSEcCtD
Valproic Acid—Pruritus—Arformoterol—chronic obstructive pulmonary disease	7.11e-05	0.000705	CcSEcCtD
Valproic Acid—Pruritus—Formoterol—chronic obstructive pulmonary disease	7.11e-05	0.000705	CcSEcCtD
Valproic Acid—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	7.1e-05	0.000704	CcSEcCtD
Valproic Acid—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	7.1e-05	0.000704	CcSEcCtD
Valproic Acid—Asthenia—Montelukast—chronic obstructive pulmonary disease	7.06e-05	0.000701	CcSEcCtD
Valproic Acid—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	6.99e-05	0.000694	CcSEcCtD
Valproic Acid—Pruritus—Montelukast—chronic obstructive pulmonary disease	6.96e-05	0.000691	CcSEcCtD
Valproic Acid—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	6.88e-05	0.000682	CcSEcCtD
Valproic Acid—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	6.88e-05	0.000682	CcSEcCtD
Valproic Acid—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	6.84e-05	0.000679	CcSEcCtD
Valproic Acid—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	6.82e-05	0.000677	CcSEcCtD
Valproic Acid—Asthenia—Salbutamol—chronic obstructive pulmonary disease	6.81e-05	0.000676	CcSEcCtD
Valproic Acid—Sweating increased—Prednisone—chronic obstructive pulmonary disease	6.77e-05	0.000672	CcSEcCtD
Valproic Acid—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	6.73e-05	0.000668	CcSEcCtD
Valproic Acid—Pruritus—Salbutamol—chronic obstructive pulmonary disease	6.71e-05	0.000666	CcSEcCtD
Valproic Acid—Dizziness—Formoterol—chronic obstructive pulmonary disease	6.64e-05	0.000659	CcSEcCtD
Valproic Acid—Dizziness—Arformoterol—chronic obstructive pulmonary disease	6.64e-05	0.000659	CcSEcCtD
Valproic Acid—Dizziness—Montelukast—chronic obstructive pulmonary disease	6.51e-05	0.000646	CcSEcCtD
Valproic Acid—Neutropenia—Prednisone—chronic obstructive pulmonary disease	6.5e-05	0.000645	CcSEcCtD
Valproic Acid—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	6.49e-05	0.000644	CcSEcCtD
Valproic Acid—Vomiting—Formoterol—chronic obstructive pulmonary disease	6.39e-05	0.000634	CcSEcCtD
Valproic Acid—Vomiting—Arformoterol—chronic obstructive pulmonary disease	6.39e-05	0.000634	CcSEcCtD
Valproic Acid—Rash—Arformoterol—chronic obstructive pulmonary disease	6.34e-05	0.000629	CcSEcCtD
Valproic Acid—Rash—Formoterol—chronic obstructive pulmonary disease	6.34e-05	0.000629	CcSEcCtD
Valproic Acid—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	6.33e-05	0.000628	CcSEcCtD
Valproic Acid—Dermatitis—Formoterol—chronic obstructive pulmonary disease	6.33e-05	0.000628	CcSEcCtD
Valproic Acid—Weight increased—Prednisone—chronic obstructive pulmonary disease	6.33e-05	0.000628	CcSEcCtD
Valproic Acid—Headache—Arformoterol—chronic obstructive pulmonary disease	6.3e-05	0.000625	CcSEcCtD
Valproic Acid—Headache—Formoterol—chronic obstructive pulmonary disease	6.3e-05	0.000625	CcSEcCtD
Valproic Acid—Weight decreased—Prednisone—chronic obstructive pulmonary disease	6.29e-05	0.000624	CcSEcCtD
Valproic Acid—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	6.28e-05	0.000624	CcSEcCtD
Valproic Acid—Dizziness—Salbutamol—chronic obstructive pulmonary disease	6.27e-05	0.000623	CcSEcCtD
Valproic Acid—Vomiting—Montelukast—chronic obstructive pulmonary disease	6.26e-05	0.000621	CcSEcCtD
Valproic Acid—Rash—Montelukast—chronic obstructive pulmonary disease	6.21e-05	0.000616	CcSEcCtD
Valproic Acid—Dermatitis—Montelukast—chronic obstructive pulmonary disease	6.2e-05	0.000615	CcSEcCtD
Valproic Acid—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	6.19e-05	0.000614	CcSEcCtD
Valproic Acid—Depression—Prednisone—chronic obstructive pulmonary disease	6.18e-05	0.000613	CcSEcCtD
Valproic Acid—Headache—Montelukast—chronic obstructive pulmonary disease	6.17e-05	0.000612	CcSEcCtD
Valproic Acid—Angioedema—Prednisolone—chronic obstructive pulmonary disease	6.09e-05	0.000605	CcSEcCtD
Valproic Acid—Vomiting—Salbutamol—chronic obstructive pulmonary disease	6.03e-05	0.000599	CcSEcCtD
Valproic Acid—Malaise—Prednisolone—chronic obstructive pulmonary disease	6.01e-05	0.000597	CcSEcCtD
Valproic Acid—Vertigo—Prednisolone—chronic obstructive pulmonary disease	5.99e-05	0.000594	CcSEcCtD
Valproic Acid—Rash—Salbutamol—chronic obstructive pulmonary disease	5.98e-05	0.000594	CcSEcCtD
Valproic Acid—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	5.98e-05	0.000593	CcSEcCtD
Valproic Acid—Nausea—Arformoterol—chronic obstructive pulmonary disease	5.97e-05	0.000592	CcSEcCtD
Valproic Acid—Nausea—Formoterol—chronic obstructive pulmonary disease	5.97e-05	0.000592	CcSEcCtD
Valproic Acid—Headache—Salbutamol—chronic obstructive pulmonary disease	5.94e-05	0.00059	CcSEcCtD
Valproic Acid—Nausea—Montelukast—chronic obstructive pulmonary disease	5.85e-05	0.00058	CcSEcCtD
Valproic Acid—Hypertension—Prednisolone—chronic obstructive pulmonary disease	5.76e-05	0.000571	CcSEcCtD
Valproic Acid—Bradycardia—Prednisone—chronic obstructive pulmonary disease	5.67e-05	0.000562	CcSEcCtD
Valproic Acid—Nausea—Salbutamol—chronic obstructive pulmonary disease	5.64e-05	0.000559	CcSEcCtD
Valproic Acid—Discomfort—Prednisolone—chronic obstructive pulmonary disease	5.61e-05	0.000557	CcSEcCtD
Valproic Acid—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	5.59e-05	0.000555	CcSEcCtD
Valproic Acid—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	5.57e-05	0.000552	CcSEcCtD
Valproic Acid—Hallucination—Prednisone—chronic obstructive pulmonary disease	5.54e-05	0.00055	CcSEcCtD
Valproic Acid—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	5.47e-05	0.000543	CcSEcCtD
Valproic Acid—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	5.44e-05	0.00054	CcSEcCtD
Valproic Acid—Oedema—Prednisolone—chronic obstructive pulmonary disease	5.44e-05	0.00054	CcSEcCtD
Valproic Acid—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	5.31e-05	0.000527	CcSEcCtD
Valproic Acid—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	5.26e-05	0.000522	CcSEcCtD
Valproic Acid—Eye disorder—Prednisone—chronic obstructive pulmonary disease	5.2e-05	0.000516	CcSEcCtD
Valproic Acid—Angiopathy—Prednisone—chronic obstructive pulmonary disease	5.05e-05	0.000501	CcSEcCtD
Valproic Acid—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	5.03e-05	0.000499	CcSEcCtD
Valproic Acid—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	4.97e-05	0.000493	CcSEcCtD
Valproic Acid—Insomnia—Prednisolone—chronic obstructive pulmonary disease	4.92e-05	0.000488	CcSEcCtD
Valproic Acid—Alopecia—Prednisone—chronic obstructive pulmonary disease	4.92e-05	0.000488	CcSEcCtD
Valproic Acid—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	4.89e-05	0.000485	CcSEcCtD
Valproic Acid—Mental disorder—Prednisone—chronic obstructive pulmonary disease	4.88e-05	0.000484	CcSEcCtD
Valproic Acid—Malnutrition—Prednisone—chronic obstructive pulmonary disease	4.85e-05	0.000481	CcSEcCtD
Valproic Acid—Pain—Prednisolone—chronic obstructive pulmonary disease	4.65e-05	0.000462	CcSEcCtD
Valproic Acid—Vision blurred—Prednisone—chronic obstructive pulmonary disease	4.57e-05	0.000453	CcSEcCtD
Valproic Acid—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	4.5e-05	0.000446	CcSEcCtD
Valproic Acid—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	4.48e-05	0.000445	CcSEcCtD
Valproic Acid—Anaemia—Prednisone—chronic obstructive pulmonary disease	4.48e-05	0.000444	CcSEcCtD
Valproic Acid—Agitation—Prednisone—chronic obstructive pulmonary disease	4.45e-05	0.000442	CcSEcCtD
Valproic Acid—Angioedema—Prednisone—chronic obstructive pulmonary disease	4.43e-05	0.000439	CcSEcCtD
Valproic Acid—Malaise—Prednisone—chronic obstructive pulmonary disease	4.37e-05	0.000434	CcSEcCtD
Valproic Acid—Vertigo—Prednisone—chronic obstructive pulmonary disease	4.35e-05	0.000432	CcSEcCtD
Valproic Acid—Urticaria—Prednisolone—chronic obstructive pulmonary disease	4.32e-05	0.000429	CcSEcCtD
Valproic Acid—Hypertension—Prednisone—chronic obstructive pulmonary disease	4.18e-05	0.000415	CcSEcCtD
Valproic Acid—Arthralgia—Prednisone—chronic obstructive pulmonary disease	4.13e-05	0.000409	CcSEcCtD
Valproic Acid—Myalgia—Prednisone—chronic obstructive pulmonary disease	4.13e-05	0.000409	CcSEcCtD
Valproic Acid—Anxiety—Prednisone—chronic obstructive pulmonary disease	4.11e-05	0.000408	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	4.1e-05	0.000407	CcSEcCtD
Valproic Acid—Discomfort—Prednisone—chronic obstructive pulmonary disease	4.08e-05	0.000404	CcSEcCtD
Valproic Acid—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	4.01e-05	0.000398	CcSEcCtD
Valproic Acid—Oedema—Prednisone—chronic obstructive pulmonary disease	3.95e-05	0.000392	CcSEcCtD
Valproic Acid—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	3.95e-05	0.000392	CcSEcCtD
Valproic Acid—Infection—Prednisone—chronic obstructive pulmonary disease	3.93e-05	0.00039	CcSEcCtD
Valproic Acid—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	3.88e-05	0.000385	CcSEcCtD
Valproic Acid—Tachycardia—Prednisone—chronic obstructive pulmonary disease	3.86e-05	0.000383	CcSEcCtD
Valproic Acid—Skin disorder—Prednisone—chronic obstructive pulmonary disease	3.84e-05	0.000381	CcSEcCtD
Valproic Acid—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	3.82e-05	0.000379	CcSEcCtD
Valproic Acid—Anorexia—Prednisone—chronic obstructive pulmonary disease	3.77e-05	0.000374	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	3.6e-05	0.000358	CcSEcCtD
Valproic Acid—Dizziness—Prednisolone—chronic obstructive pulmonary disease	3.6e-05	0.000357	CcSEcCtD
Valproic Acid—Insomnia—Prednisone—chronic obstructive pulmonary disease	3.58e-05	0.000355	CcSEcCtD
Valproic Acid—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	3.55e-05	0.000352	CcSEcCtD
Valproic Acid—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	3.48e-05	0.000345	CcSEcCtD
Valproic Acid—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	3.44e-05	0.000341	CcSEcCtD
Valproic Acid—Rash—Prednisolone—chronic obstructive pulmonary disease	3.43e-05	0.00034	CcSEcCtD
Valproic Acid—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	3.43e-05	0.00034	CcSEcCtD
Valproic Acid—Fatigue—Prednisone—chronic obstructive pulmonary disease	3.41e-05	0.000338	CcSEcCtD
Valproic Acid—Headache—Prednisolone—chronic obstructive pulmonary disease	3.41e-05	0.000338	CcSEcCtD
Valproic Acid—Constipation—Prednisone—chronic obstructive pulmonary disease	3.38e-05	0.000336	CcSEcCtD
Valproic Acid—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	3.26e-05	0.000323	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	3.23e-05	0.000321	CcSEcCtD
Valproic Acid—Nausea—Prednisolone—chronic obstructive pulmonary disease	3.23e-05	0.000321	CcSEcCtD
Valproic Acid—Urticaria—Prednisone—chronic obstructive pulmonary disease	3.14e-05	0.000312	CcSEcCtD
Valproic Acid—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	3.13e-05	0.00031	CcSEcCtD
Valproic Acid—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	3.13e-05	0.00031	CcSEcCtD
Valproic Acid—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	2.91e-05	0.000289	CcSEcCtD
Valproic Acid—Asthenia—Prednisone—chronic obstructive pulmonary disease	2.84e-05	0.000282	CcSEcCtD
Valproic Acid—Pruritus—Prednisone—chronic obstructive pulmonary disease	2.8e-05	0.000278	CcSEcCtD
Valproic Acid—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	2.71e-05	0.000268	CcSEcCtD
Valproic Acid—Dizziness—Prednisone—chronic obstructive pulmonary disease	2.62e-05	0.000259	CcSEcCtD
Valproic Acid—Vomiting—Prednisone—chronic obstructive pulmonary disease	2.51e-05	0.000249	CcSEcCtD
Valproic Acid—Rash—Prednisone—chronic obstructive pulmonary disease	2.49e-05	0.000247	CcSEcCtD
Valproic Acid—Dermatitis—Prednisone—chronic obstructive pulmonary disease	2.49e-05	0.000247	CcSEcCtD
Valproic Acid—Headache—Prednisone—chronic obstructive pulmonary disease	2.48e-05	0.000246	CcSEcCtD
Valproic Acid—Nausea—Prednisone—chronic obstructive pulmonary disease	2.35e-05	0.000233	CcSEcCtD
Valproic Acid—SLC16A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.25e-05	0.000163	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.24e-05	0.000162	CbGpPWpGaD
Valproic Acid—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	1.24e-05	0.000162	CbGpPWpGaD
Valproic Acid—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.23e-05	0.000161	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	1.22e-05	0.00016	CbGpPWpGaD
Valproic Acid—CYP2A6—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	1.22e-05	0.00016	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—KL—chronic obstructive pulmonary disease	1.21e-05	0.000159	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.2e-05	0.000157	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—CTGF—chronic obstructive pulmonary disease	1.2e-05	0.000156	CbGpPWpGaD
Valproic Acid—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.18e-05	0.000155	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.18e-05	0.000155	CbGpPWpGaD
Valproic Acid—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.17e-05	0.000153	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—ALB—chronic obstructive pulmonary disease	1.16e-05	0.000152	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.16e-05	0.000152	CbGpPWpGaD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.15e-05	0.000151	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—GCLC—chronic obstructive pulmonary disease	1.15e-05	0.00015	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.13e-05	0.000147	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	1.12e-05	0.000146	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—GCLC—chronic obstructive pulmonary disease	1.11e-05	0.000146	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—NOS3—chronic obstructive pulmonary disease	1.11e-05	0.000145	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.11e-05	0.000145	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.1e-05	0.000144	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.09e-05	0.000143	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.07e-05	0.00014	CbGpPWpGaD
Valproic Acid—SLC22A5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.07e-05	0.00014	CbGpPWpGaD
Valproic Acid—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.05e-05	0.000137	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.05e-05	0.000137	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—CTGF—chronic obstructive pulmonary disease	1.05e-05	0.000137	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	1.04e-05	0.000136	CbGpPWpGaD
Valproic Acid—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.04e-05	0.000135	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.03e-05	0.000135	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	1.02e-05	0.000133	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—CTGF—chronic obstructive pulmonary disease	1.02e-05	0.000133	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—ALB—chronic obstructive pulmonary disease	1.02e-05	0.000133	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.02e-05	0.000133	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.01e-05	0.000132	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—VEGFA—chronic obstructive pulmonary disease	9.92e-06	0.00013	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—IL6—chronic obstructive pulmonary disease	9.91e-06	0.00013	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.86e-06	0.000129	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.85e-06	0.000129	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	9.77e-06	0.000128	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.72e-06	0.000127	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—NOS3—chronic obstructive pulmonary disease	9.72e-06	0.000127	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.7e-06	0.000127	CbGpPWpGaD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.69e-06	0.000127	CbGpPWpGaD
Valproic Acid—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.65e-06	0.000126	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.63e-06	0.000126	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.63e-06	0.000126	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	9.53e-06	0.000125	CbGpPWpGaD
Valproic Acid—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.51e-06	0.000124	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.48e-06	0.000124	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.37e-06	0.000123	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—TGFB1—chronic obstructive pulmonary disease	9.3e-06	0.000122	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.19e-06	0.00012	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.16e-06	0.00012	CbGpPWpGaD
Valproic Acid—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.14e-06	0.00012	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—EGFR—chronic obstructive pulmonary disease	9.12e-06	0.000119	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—TGFB1—chronic obstructive pulmonary disease	9.11e-06	0.000119	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—ERBB3—chronic obstructive pulmonary disease	9.1e-06	0.000119	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.08e-06	0.000119	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—VEGFA—chronic obstructive pulmonary disease	9.07e-06	0.000119	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.07e-06	0.000119	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—GCLC—chronic obstructive pulmonary disease	9.06e-06	0.000118	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.06e-06	0.000118	CbGpPWpGaD
Valproic Acid—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.02e-06	0.000118	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	9e-06	0.000118	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	8.83e-06	0.000116	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.73e-06	0.000114	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	8.72e-06	0.000114	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.59e-06	0.000112	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.5e-06	0.000111	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—ALB—chronic obstructive pulmonary disease	8.48e-06	0.000111	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.45e-06	0.00011	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.45e-06	0.00011	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—TGFB1—chronic obstructive pulmonary disease	8.33e-06	0.000109	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—CTGF—chronic obstructive pulmonary disease	8.27e-06	0.000108	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.21e-06	0.000107	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—NOS3—chronic obstructive pulmonary disease	8.11e-06	0.000106	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.1e-06	0.000106	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.09e-06	0.000106	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	8.04e-06	0.000105	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.03e-06	0.000105	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.01e-06	0.000105	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	7.95e-06	0.000104	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.92e-06	0.000104	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.9e-06	0.000103	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	7.88e-06	0.000103	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	7.84e-06	0.000103	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.82e-06	0.000102	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.71e-06	0.000101	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.62e-06	9.96e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—NOS2—chronic obstructive pulmonary disease	7.58e-06	9.92e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—TP53—chronic obstructive pulmonary disease	7.5e-06	9.8e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.47e-06	9.77e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.39e-06	9.66e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.38e-06	9.66e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	7.38e-06	9.66e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	7.36e-06	9.62e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.33e-06	9.59e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	7.33e-06	9.58e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	7.19e-06	9.4e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.18e-06	9.39e-05	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.09e-06	9.28e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.06e-06	9.24e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.01e-06	9.17e-05	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—IL6—chronic obstructive pulmonary disease	7.01e-06	9.16e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7e-06	9.15e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	6.98e-06	9.13e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.88e-06	9e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	6.88e-06	9e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—TP53—chronic obstructive pulmonary disease	6.86e-06	8.97e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.81e-06	8.91e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.8e-06	8.89e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	6.74e-06	8.81e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.68e-06	8.74e-05	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—ALB—chronic obstructive pulmonary disease	6.55e-06	8.56e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.54e-06	8.56e-05	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.51e-06	8.52e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—SERPINE1—chronic obstructive pulmonary disease	6.39e-06	8.35e-05	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.38e-06	8.35e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	6.37e-06	8.33e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.37e-06	8.33e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.35e-06	8.31e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.31e-06	8.26e-05	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—NOS3—chronic obstructive pulmonary disease	6.26e-06	8.19e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.26e-06	8.19e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.21e-06	8.12e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	6.14e-06	8.03e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.13e-06	8.02e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—NOS3—chronic obstructive pulmonary disease	6.1e-06	7.97e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.87e-06	7.68e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.84e-06	7.64e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.84e-06	7.63e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—ALB—chronic obstructive pulmonary disease	5.84e-06	7.63e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.71e-06	7.47e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.7e-06	7.45e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.7e-06	7.45e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	5.63e-06	7.37e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.58e-06	7.3e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.57e-06	7.29e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.53e-06	7.24e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	5.51e-06	7.2e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—ALB—chronic obstructive pulmonary disease	5.44e-06	7.12e-05	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.36e-06	7.01e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.32e-06	6.96e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—NOS3—chronic obstructive pulmonary disease	5.21e-06	6.81e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.18e-06	6.77e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	5.14e-06	6.72e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.11e-06	6.68e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	5.02e-06	6.57e-05	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.91e-06	6.42e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.9e-06	6.4e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.87e-06	6.37e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.83e-06	6.32e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.83e-06	6.31e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	4.77e-06	6.24e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.76e-06	6.22e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—ALB—chronic obstructive pulmonary disease	4.76e-06	6.22e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	4.74e-06	6.2e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.74e-06	6.19e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.63e-06	6.06e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—ALB—chronic obstructive pulmonary disease	4.63e-06	6.05e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—NOS3—chronic obstructive pulmonary disease	4.55e-06	5.95e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.55e-06	5.95e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.51e-06	5.9e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.5e-06	5.88e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.47e-06	5.85e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.45e-06	5.82e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—NOS3—chronic obstructive pulmonary disease	4.43e-06	5.79e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.41e-06	5.76e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	4.35e-06	5.69e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.31e-06	5.63e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.27e-06	5.58e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.27e-06	5.58e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	4.26e-06	5.57e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—TGFB1—chronic obstructive pulmonary disease	4.03e-06	5.27e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.01e-06	5.24e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.97e-06	5.19e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—EGFR—chronic obstructive pulmonary disease	3.95e-06	5.17e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.95e-06	5.17e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.93e-06	5.14e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.9e-06	5.1e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	3.88e-06	5.08e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	3.88e-06	5.08e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.86e-06	5.05e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.81e-06	4.98e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.79e-06	4.95e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—ALB—chronic obstructive pulmonary disease	3.76e-06	4.92e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.63e-06	4.75e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.62e-06	4.73e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.6e-06	4.71e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.58e-06	4.68e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.55e-06	4.64e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	3.54e-06	4.63e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.44e-06	4.5e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.43e-06	4.48e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.36e-06	4.4e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.36e-06	4.39e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.34e-06	4.37e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	3.32e-06	4.34e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.3e-06	4.31e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.26e-06	4.27e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.09e-06	4.05e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.08e-06	4.02e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.07e-06	4.02e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	3.07e-06	4.01e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—IL6—chronic obstructive pulmonary disease	3.04e-06	3.97e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	3.03e-06	3.96e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.99e-06	3.9e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.94e-06	3.85e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.93e-06	3.84e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.91e-06	3.81e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	2.9e-06	3.79e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.82e-06	3.69e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.77e-06	3.63e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.77e-06	3.62e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.74e-06	3.59e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.72e-06	3.56e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.68e-06	3.51e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.6e-06	3.4e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.59e-06	3.39e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	2.56e-06	3.35e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.5e-06	3.27e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.37e-06	3.1e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	2.34e-06	3.06e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	2.34e-06	3.06e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.33e-06	3.04e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.32e-06	3.04e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.29e-06	3e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	2.29e-06	2.99e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.24e-06	2.93e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	2.19e-06	2.86e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.15e-06	2.82e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.14e-06	2.8e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.13e-06	2.78e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.03e-06	2.65e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	1.98e-06	2.59e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	1.89e-06	2.48e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.8e-06	2.35e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.77e-06	2.32e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	1.77e-06	2.31e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	1.69e-06	2.21e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.65e-06	2.16e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	1.61e-06	2.11e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.56e-06	2.05e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.54e-06	2.02e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.38e-06	1.8e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.32e-06	1.72e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.06e-06	1.39e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.02e-06	1.33e-05	CbGpPWpGaD
